Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Targeting Reward Circuits: Psilocybin as a Novel Therapy for Residual AnhedoniaClinicalTrials.gov · 2026-09-15Brain-wide reconfiguration of burst firing by psilocybin reveals 5-HT2A-dependent circuit dynamicsbioRxiv · 2026-09-07A Phase 2b/3, Multicentre, Randomised, Double-blind, Controlled Trial, With an Open Label Extension, to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress DisorderClinicalTrials.gov · 2026-09-04Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for Alcohol Use DisorderClinicalTrials.gov · 2026-09-02Mycotoxins in Basidiomycete Mycelium and Fruiting Bodies: Implications for Eu Novel Food Assessment and Selected International Regulatory Frameworks.Comprehensive reviews in food science and food safety · 2026-09-01A dominant frontoparietal beta oscillatory brain state in the days after psilocybin and 5-MeO-DMTbioRxiv · 2026-08-27Appetite for change: How nutritional state and ventral striatal dopamine shape psilocybin effects on cognitive flexibilitybioRxiv · 2026-08-23Psilocybin lengthens hippocampal sharp wave ripplesbioRxiv · 2026-08-20Sex Differences in Acute Responses to Psychedelics: Evidence for Greater Subjective Intensity and Impairment in Female ParticipantsbioRxiv · 2026-08-19Psilocybin in Chronic Low Back Pain: An Integrative Study of Lab-Based Mechanisms and Real-World Physical Therapy OutcomesClinicalTrials.gov · 2026-08-19Psilocybin asymmetrically modulates outcome-based choice and cortical processing under uncertaintybioRxiv · 2026-08-13Processing Intergenerational Trauma With Psilocybin-Assisted TherapyClinicalTrials.gov · 2026-08-13Investigating the Effects of Psilocybin on Cognitive Flexibility in Touchscreen and Naturalistic Variations of the Probabilistic Reversal Learning TaskbioRxiv · 2026-08-12Low-Dose Psilocybin Therapy for Palliative Care Patients With Chronic Cancer Pain Requiring OpioidsClinicalTrials.gov · 2026-08-12A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10Safety, Tolerability, Outcomes of Psilocybin for Depression (STOP Depression) in Veterans With Spinal Cord InjuryClinicalTrials.gov · 2026-08-10A Phase III, Multicentre, Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10A Multicenter Phase 1 Safety and Tolerability Trial of Psilocybin in Healthy Older AdultsClinicalTrials.gov · 2026-08-10Mapping excitatory synaptic plasticity evoked by single-dose psilocybin in micebioRxiv · 2026-08-05Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic TherapiesClinicalTrials.gov · 2026-08-04Simulated 5-HT2A receptor activation accounts for the high complexity of brain activity during psychedelic statesbioRxiv · 2026-08-04One Dose of Psilocybin May Alter Brain StructurePsychiatric News · 2026-08-01Ethical Complexities and Best Practices in Informed Consent Processes for Psilocybin Services: A Qualitative StudyNeuroethics · 2026-08-01Network Pharmacology-Guided Discovery of Fungal Autophagy Modulators for Tauopathies: Structural and Proteomic EvidencebioRxiv · 2026-07-27A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Psilocybin in Adults With Major Depressive Disorder (MDD)ClinicalTrials.gov · 2026-07-23The Efficacy of Psilocybin Therapy for Depression in Parkinson's DiseaseClinicalTrials.gov · 2026-07-20PSilocybin Microdose for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site Phase 3 Double-blind, Placebo-controlled, Parallel-arm Clinical TrialClinicalTrials.gov · 2026-07-10The Effects of Psilocybin on Social ConnectednessClinicalTrials.gov · 2026-07-09Exploration of Synaptotrophic Effects of Psilocybin in Opioid Use Disorder (OUD)ClinicalTrials.gov · 2026-07-07Psilocybin helps woman with Alzheimer'sNew Scientist · 2026-07-01Improving access to novel treatments for treatment-resistant depression: The potential role of specialist clinics in Australia.The Australian and New Zealand journal of psychiatry · 2026-07-015-HT2A Agonist Psilocybin in the Treatment of Tobacco Use DisorderClinicalTrials.gov · 2026-06-29Effects of Repeated Dosing of Psilocybin on Obsessive-Compulsive Disorder: A Randomized, Waitlist-Controlled StudyClinicalTrials.gov · 2026-06-04Group Psilocybin-Assisted Therapy for Post-Traumatic Stress DisorderClinicalTrials.gov · 2026-05-22A Randomized, Double-Blind Study of Single-Dose Psilocybin for Major Depressive Disorder (MDD)ClinicalTrials.gov · 2026-04-22Observing the mind under psychedelics: conceptual metaphors used following four once-weekly macrodoses of psilocybinPhilosophical Psychology · 2026-04-10Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic TherapiesClinicalTrials.gov · 2026-03-20Safety, Feasibility, and Tolerability of Psilocybin Treatment for Individuals With Functional Impairment Related to Mood, Anxiety, Trauma and/or Addiction Symptoms: An Open-label Proof-of-concept StudyClinicalTrials.gov · 2026-03-11Pilot Proof of Concept Study Evaluating the Potential Psilocybin Assisted Psychotherapy (PAP) as a Therapeutic Tool for Patients Suffering From Severe Irritable Bowel Syndrome.ClinicalTrials.gov · 2026-03-05Psilocybin in the real world: Regulatory, ethical, and operational challenges in Australia's clinical landscape.The Australian and New Zealand journal of psychiatry · 2026-02-01Hope for Neurotic Disorders: A Summary of New Zealand Research on the Development of Biomarkers and Novel Treatments.Journal of the Royal Society of New Zealand · 2026-02-01A Phase 2 Trial of Psilocybin as an Adjunctive Treatment for OUD Patients Who Continue to Use Illicit Opioids Despite Adherence to Methadone TreatmentClinicalTrials.gov · 2026-01-23Effects of Psilocybin on Speech Fluency, Struggle, and Brain Activity in People Who StutterClinicalTrials.gov · 2025-12-22A Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Effects of Psilocybin-assisted Psychotherapy on Psychiatric and Existential Distress in Advanced CancerClinicalTrials.gov · 2025-12-04Reappraisal of the hype and hope offered by psilocybin treatment of depression.The New Zealand medical journal · 2025-09-19We may know why psilocybin helps treat mental health conditionsThe New Scientist · 2025-09-01Attitudes toward psychedelics and psychedelic-assisted psychotherapy among Australian mental healthcare providers.The Australian and New Zealand journal of psychiatry · 2025-09-01Equitable access to psilocybin-assisted psychotherapy in New Zealand.The New Zealand medical journal · 2025-07-11The Safety and Tolerability of COMP360 in Participants With Post-traumatic Stress DisorderClinicalTrials.gov · 2025-06-13Investigating the Role of Serotonin in the Mechanism of Action of Psilocybin in Patients With Major Depressive DisorderClinicalTrials.gov · 2025-05-14Psilocybin-assisted Interpersonal Therapy for DepressionClinicalTrials.gov · 2025-04-09Psilocybin Treatment in Obsessive-Compulsive Disorder: a Preliminary Efficacy Study and Exploratory Investigation of Neural Correlates.ClinicalTrials.gov · 2024-11-20A taxonomy of regulatory and policy matters relevant to psychedelic-assisted therapy in Australia.The Australian and New Zealand journal of psychiatry · 2024-07-01Psychedelics’ Use as Medicine Hits Significant RoadblockPsychiatric News · 2024-06-12Calls to Poison Centers Involving Psilocybin Rising in YouthPsychiatric News · 2024-05-10MedCheck: Psilocybin for Depression, LSD for Anxiety, Donanemab, LSD, and MorePsychiatric News · 2024-04-23MedCheck; Psilocybin, Roluperidone, Latozinemab, LacosamidePsychiatric News · 2024-03-26Psychedelic Renaissance: Evidence and CulturePsychiatric News · 2024-03-21Effects and Therapeutic Potential of Psilocybin in Alcohol DependenceClinicalTrials.gov · 2023-09-26Australia Legalizes Psychedelics for Use in Depression, PTSD TherapyPsychiatric News · 2023-08-15Med Check: FDA, Anti-Amyloid Beta Vaccine, Clinical Trials of Psychedelics, and LumryzPsychiatric News · 2023-07-27Psychedelic drug psilocybin shows promise treating anorexia in early trialsThe New Scientist · 2023-07-01Why didn't the TGA consult with Australian researchers and clinicians with experience in psilocybin-assisted psychotherapy for treatment-resistant major depressive disorder?The Australian and New Zealand journal of psychiatry · 2023-07-01The down-scheduling of MDMA and psilocybin(e): Too fast and too soon.The Australian and New Zealand journal of psychiatry · 2023-07-01Experts Offer Tips on Talking With Patients About PsychedelicsPsychiatric News · 2023-06-28Psychedelic Therapy Requires Enhanced Consent DiscussionsPsychiatric News · 2023-06-28The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant DepressionClinicalTrials.gov · 2023-04-24Experts to Discuss the Ethics of PsychedelicsPsychiatric News · 2023-03-27Safety and Efficacy of Psilocybin for Body Dysmorphic DisorderClinicalTrials.gov · 2023-03-13Psilocybin for Treatment-Resistant Depression.The New England journal of medicine · 2023-02-23Psychedelic Renaissance: Clinical Health Justice, Patient Safety, and Equity Need to Be Put FirstPsychiatric News · 2023-02-16Psychedelics Legislation Gains MomentumPsychiatric News · 2023-02-16Depression Improves Following Single Dose of PsilocybinPsychiatric News · 2022-12-26A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol DependenceClinicalTrials.gov · 2022-11-08Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.The New England journal of medicine · 2022-11-03Med Check: Psilocybin for OCD, Nuplazid Vote, and MorePsychiatric News · 2022-08-01Psilocybin-Assisted Therapy Found to Improve Depression, Offer Other BenefitsPsychiatric News · 2022-05-23Demystifying Psychedelic Treatments in Psychiatry: Is Ego Dissolution the Solution?Psychiatric News · 2022-03-24A Randomized Controlled Trial of the Effects of Psilocybin-Facilitated Experience on the Psychology and Effectiveness of Professional Leaders in ReligionClinicalTrials.gov · 2022-02-14Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm.The Australian and New Zealand journal of psychiatry · 2021-12-01Marijuana, Hallucinogen Use Reach Historic Levels Among Young AdultsPsychiatric News · 2021-11-30Psychedelic Drugs for Mental Disorders and Human Potential: Placebo or PanaceaPsychiatric News · 2021-11-29Psilocybin steps closer to credibilityThe New Scientist · 2021-11-01Psilocybin for Depression.The New England journal of medicine · 2021-08-26Psychedelic Therapy Hits Another Milestone, But Caution UrgedPsychiatric News · 2021-07-22Trial of Psilocybin versus Escitalopram for Depression.The New England journal of medicine · 2021-04-15Back to the Future - The Therapeutic Potential of Psychedelic DrugsNew England Journal of Medicine · 2021-04-14The Return of Psychedelics: Still Time to Prevent TragedyPsychiatric News · 2021-03-31Session on Psychedelics Sure to Be EnlighteningPsychiatric News · 2021-03-01The Effect of Psilocybin on PersonalityCUNY Academic Works (City University of New York) · 2020-12-31Effects of Psilocybin on Anxiety and Psychosocial Distress in Cancer PatientsClinicalTrials.gov · 2020-10-20Wait for the Science Before Widespread Use of PsilocybinPsychiatric News · 2020-09-29Journal Digest: Home Environment; Postpartum Mental Illness; Placebo in Psychedelic Study; Single Gene Mutation; TopiramatePsychiatric News · 2020-05-28Psychedelics for Psychiatric Disorders: More Research NeededPsychiatric News · 2020-04-13Can Psychedelics Radically Change SUD Treatment?Psychiatric News · 2020-03-20Psilocybin-assisted therapy for depression: How do we advance the field?The Australian and New Zealand journal of psychiatry · 2020-03-01Analysis of Newspaper Coverage of Psilocybin from January 1, 1989 to December 31, 2019CUNY Academic Works (City University of New York) · 2019-12-31Johns Hopkins Opens Research Center on PsychedelicsPsychiatric News · 2019-10-27Psychedelic Medicine: Careful Studies, Regulations Are the AnswerPsychiatric News · 2019-04-30Is Psychedelic Medicine on the Horizon?Psychiatric News · 2019-02-28Can psychedelic drug help with depression?The New Scientist · 2018-01-31My Experience as a Guide in the Johns Hopkins Psilocybin Research ProjectMAPS Bulletin · 2014-01-01Study Suggests Hallucinogen May Be Personality ChangerPsychiatric News · 2011-12-16Benefits of 'magic mushroom' therapy long lastingNature · 2008-07-03Psilocybin Results Inspire ResearchersClinical Psychiatry News · 2007-07-01PSILOCYBIN STUDIES TURN A NEW LEAFChemical & Engineering News · 2006-07-16Designer HallucinogensEmergency Medicine News · 2003-12-01Effects of mescaline and psilocin on acquisition, consolidation, and performance of light-dark discrimination in two inbred strains of micePsychopharmacology · 1978-01-01